Drug Updates

JB Pharma to Acquire the Entire Razel (Rosuvastatin) Franchise for Rs. 314 Crores

The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country JB Pharma, one of the fastest growing pharmaceutical companies in India, has entered into an agreement with Glenmark Pharmaceuticals Ltd., to […]

Drug Updates

JB Pharma Reduces Price of AZMARDA (Sacubitril-Valsartan®) by Nearly 50%

JB Chemicals & Pharmaceuticals Ltd (JB Pharma), one of the fastest-growing pharmaceutical companies in India, announced a substantial price decrease of approximately 50% for the critical heart failure drug “Azmarda”.  Azmarda, which contains the patented molecule Saccubutril-Valsartan® is indicated for Heart failure which ails 8 to 12 million people in the country. After the price […]

Drug Updates

JB Pharma Announces USFDA Approval for its Generic Venlafaxine Extended-Release Tablets

JB Pharma, one of the fastest growing pharmaceutical companies in India, today, has announced that it has received final approval from USFDA for its Abbreviated New Drug Application (ANDA), Venlafaxine Extended-Release Tablets 37.5 mg, 75 mg, 150 mg and 225 mg. This product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an […]